The words you are searching are inside this book. To get more targeted content, please make full-text search by clicking here.
The global spinal muscular atrophy (SMA) treatment market was valued at USD 1.72 billion in 2018 and is expected to grow significantly, reaching USD 31.89 billion by 2032, driven by a robust compound annual growth rate (CAGR) of 21.8% over the forecast period. In 2018, North America led the market, accounting for 49.65% of the global share.
Discover the best professional documents and content resources in AnyFlip Document Base.
Search